AI assistant
Chemomab Therapeutics Ltd. — Director's Dealing 2021
Mar 25, 2021
35107_dirs_2021-03-25_55fcad5b-1d64-46fd-b211-cfeb09570a4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-03-16
Reporting Person: Mor George Adi (Director, Chief Executive Officer, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| American Depositary Shares | 649550 | Direct |
| American Depositary Shares | 514495 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to purchase American Depositary Shares | $1.49 | 2028-03-15 | American Depositary Shares (131698) | Direct | |
| Option to purchase American Depositary Shares | $0.80 | 2026-10-27 | American Depositary Shares (33725) | Indirect |
Footnotes
F1: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2: 98,770 of these options have vested and are exercisable as of the date hereof. An additional 32,928 options will become exercisable in four equal installments, at each three month anniversary of the grant date, commencing on June 15, 2021, subject to the Reporting Person's continued service.
F3: These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.